Innovative Treatment Focus VETS specializes in psychedelic-assisted therapies for PTSD, TBI, and depression, positioning it as a leader in cutting-edge mental health solutions tailored for veterans, which can attract organizations seeking advanced treatment partnerships or funding for innovative healthcare initiatives.

Strong Funding Base With over $124 million secured since 2019, VETS demonstrates significant financial backing and capacity to fund large-scale programs and research collaborations, presenting opportunities for sponsors, donors, or investors interested in expanding veteran health interventions.

Growing Advocacy Presence VETS actively engages in policy reform through leadership appointments and partnerships, such as with Columbia Psychiatry and TARA Mind, suggesting potential collaboration with organizations looking to influence or access veteran-focused legislation and policy initiatives.

Expanding Network Initiatives The launch of programs like the Ambassador Program and collaborations with diverse research entities indicates VETS' commitment to outreach and capacity-building, ripe for partnerships with organizations aiming to support veteran communities through advocacy, education, or community engagement.

Market Leadership & Recognition Co-founder Amber Capone’s repeated inclusion in the Female Founders 500 underscores leadership credibility, which can be leveraged to build credibility with corporate partners and stakeholders interested in associating with reputable and recognized veteran advocacy organizations.